Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 July 2024, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2024 to 11 July 2024
Disclaimer: If you have any questions regarding information in this press release please contact the company listed in the press release. Please do not contact EIN Presswire. We will be unable to assist you with your inquiry. EIN Presswire disclaims any content contained in these releases.